Life Expectancy News and Research

RSS

Life expectancy is the expected (in the statistical sense) number of years of life remaining at a given age. It is denoted by e''x'', which means the average number of subsequent years of life for someone now aged ''x'', according to a particular mortality experience.

Noisy road traffic may reduce life expectancy, increase stroke risk

Living in an area with noisy road traffic may reduce life expectancy, according to new research published in the European Heart Journal.

25 Jun 2015

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

The NHS is under immense pressure not only to continue to deliver improved care but also to change how it is delivering care to meet rising and changing demand with an essentially fixed amount of money and resources - all at the same time. Patience and persistence with good humour are thus vital characteristics to have.

23 Jun 2015

Isis Pharmaceuticals provides update on ISIS-SMN Rx Phase 2 study in children with SMA

Isis Pharmaceuticals, Inc. today provided an update on children with spinal muscular atrophy (SMA) who have completed the open-label, Phase 2 multiple-dose study of ISIS-SMN Rx and are continuing to receive treatment in an open-label extension (OLE) study.

22 Jun 2015

Molecules derived from avocados could help combat acute myeloid leukemia

Rich, creamy, nutritious and now cancer fighting. New research reveals that molecules derived from avocados could be effective in treating a form of cancer.

16 Jun 2015

Triciribine drug may reverse progression of pulmonary fibrosis and pulmonary hypertension

Researchers at the University of Georgia have discovered that the drug triciribine may reverse or halt the progression of pulmonary fibrosis and pulmonary hypertension, two respiratory diseases that are almost invariably fatal.

13 Jun 2015

Isis Pharmaceuticals provides update on ISIS-SMN Rx Phase 2 clinical study in infants with Type I SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open-label Phase 2 clinical study of ISIS-SMN Rx in infants with Type I spinal muscular atrophy (SMA).

11 Jun 2015

The Sandbox Project aims to improve health and wellbeing of Canadian children

Canada's leaders are playing in the sandbox to build a healthier generation of Canadians. In order to raise awareness about The Sandbox Project, Canadian Members of Parliament, Cabinet Ministers, media personalities, NGO's, families and industry professionals built sandcastles in the World's Largest Sandbox event on Sparks Street in Ottawa on Wednesday.

10 Jun 2015

Keeping blood sugar levels under control can help protect hearts from diabetes-related damage

Day in and day out, for years on end, millions of people with diabetes prick their fingers to test their blood sugar level. And many may wonder if all the careful eating, exercise and medication it takes to keep those levels under control is really worth it.

4 Jun 2015

New study shows average New Yorker sits more than seven hours a day

The Big Apple is one of the most walkable cities in the nation, providing many opportunities for physical activity, and New Yorkers are more likely to exercise regularly than the average U.S. adult. But they are also sitting far more than what is considered healthy.

3 Jun 2015

21st century trends in management of small renal cancers

A US population-based cohort study reveals a change in the management of small renal masses in the 21st century with rates of nephron-sparing surgery on the rise and a corresponding decrease in the use of radical nephrectomy.

29 May 2015

Personalized music playlists increase adherence to cardiac rehab by 70%

The use of personalized music playlists with tempo-pace synchronization increases adherence to cardiac rehab by almost 70 per cent--according to a study published in Sports Medicine -Open.

21 May 2015

One-quarter of Americans over age 65 at risk to become elder orphans

With an aging Baby Boomer population and increasing numbers of childless and unmarried seniors, nearly one-quarter of Americans over age 65 are currently or at risk to become "elder orphans," a vulnerable group requiring greater awareness and advocacy efforts, according to new research by a North Shore-LIJ geriatrician and palliative care physician.

18 May 2015

Combined therapy shows promise in cystic fibrosis patients

Treatment with two medications that target the most common genetic cause of cystic fibrosis improves lung function and lowers the rate of pulmonary exacerbations, according to the results from a Phase III international clinical trial published online in the New England Journal of Medicine on May 17, 2015.

17 May 2015

Active surveillance appears to be safer management strategy for prostate cancer patients

Four studies evaluating effectiveness, trends and other considerations for active surveillance in managing prostate cancer will be presented during the 110th Annual Scientific Meeting of the American Urological Association.

17 May 2015

WHO Press Release: World Health Statistics reports on global health goals for 194 countries

Progress in child survival worldwide is one of the greatest success stories of international development. Since 1990, child deaths have almost halved – falling from an estimated 90 deaths per 1000 live births to 46 deaths per 1000 live births in 2013...

13 May 2015

New study reveals genetic causes of rare syndrome that manifests as high blood pressure

The culmination of two decades of research, a new study reveals the genetic causes of a curious, rare syndrome that manifests as hypertension (high blood pressure) accompanied by short fingers (brachydactyly type E).

12 May 2015

Study finds extremely high levels of cardiovascular risk factors in people with psychosis

Extremely high levels of cardiovascular risk factors have been found in people with established psychosis, with central obesity evident in over 80 per cent of participants, in a study by researchers from the NIHR Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King's College London.

12 May 2015

AbbVie's venetoclax granted FDA Breakthrough Therapy Designation for CLL patients with 17p deletion

AbbVie today announced its investigational medicine venetoclax, an inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, has been granted Breakthrough Therapy Designation by the FDA for the treatment of chronic lymphocytic leukemia (CLL) in previously treated (relapsed/refractory) patients with the 17p deletion genetic mutation.

6 May 2015

1 in 5 people to develop heart failure in developed countries

One person in five is expected to develop heart failure in developed countries, a disease with no cure but which is largely preventable.